CARL · Carlsmed, Inc. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on CARL. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About CARL · Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Live Quote
SELL (score -6) · 12-1 mom -12.8% · RSI 49.2 · above_50_only · -37.1% from high
Targets blend Wall Street consensus (5 analysts: low $16.00 / mean $18.40 / high $23.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
The investigation trigger (4 Form 4 filings in 14 days) is confirmed but materially misleading. All four recent filings are RSU compensation grants to outside directors — transaction code 'A' at $0 consideration — not open-market purchases or sales that signal insider conviction. The CEO sold shares in March 2026 via a cashless option exercise (selling to cover cost basis and taxes), not a discretionary purchase of additional shares. There is no options market for CARL, making every structured-income or spread thesis unexecutable. Revenue growth of 86% YoY (Q1 2026: +58%) is genuine and the cervical platform NTAP reimbursement ($21,125 add-on) from CMS effective Oct 2025 is a real catalyst for FY26 guidance expansion to $72-77M. However, with no positive earnings path visible in any near-term window, negative forward P/E, no IV premium available, and RSI neutral-zone (40.8), there is nothing the pipeline can actually trade here.